The Sad Plight of Cell Therapy for Heart Failure: Causes and Consequences

Overview

Journal J Cardiovasc Aging

Date 2022 Apr 4

PMID 35373217

Authors

Roberto Bolli

Xian-Liang Tang

Affiliations

Soon will be listed here.

Citing Articles

Stem cell therapy for heart failure in the clinics: new perspectives in the era of precision medicine and artificial intelligence.

Chowdhury M, Zhang J, Rizk R, Chen W Front Physiol. 2024; 14:1344885.

PMID: 38264333 PMC: 10803627. DOI: 10.3389/fphys.2023.1344885.

Cardiopulmonary progenitors facilitate cardiac repair via exosomal transfer of miR-27b-3p targeting the SIK1-CREB1 axis.

Xiao Y, Xia L, Jiang W, Qin J, Zhao L, Li Z Cell Prolif. 2024; 57(5):e13593.

PMID: 38185757 PMC: 11056695. DOI: 10.1111/cpr.13593.

Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure.

Qayyum A, Mouridsen M, Nilsson B, Gustafsson I, Schou M, Nielsen O ESC Heart Fail. 2023; 10(2):1170-1183.

PMID: 36638837 PMC: 10053281. DOI: 10.1002/ehf2.14281.

References

Li Q, Guo Y, Ou Q, Chen N, Wu W, Yuan F . Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models. Basic Res Cardiol. 2011; 106(5):849-64. PMC: 3640450. DOI: 10.1007/s00395-011-0180-1. View

Eschenhagen T, Bolli R, Braun T, Field L, Fleischmann B, Frisen J . Cardiomyocyte Regeneration: A Consensus Statement. Circulation. 2017; 136(7):680-686. PMC: 5557671. DOI: 10.1161/CIRCULATIONAHA.117.029343. View

Guo Y, Wysoczynski M, Nong Y, Tomlin A, Zhu X, Gumpert A . Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction. Basic Res Cardiol. 2017; 112(2):18. PMC: 5655998. DOI: 10.1007/s00395-017-0606-5. View

Patel A, Henry T, Quyyumi A, Schaer G, Anderson R, Toma C . Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial. Lancet. 2016; 387(10036):2412-21. DOI: 10.1016/S0140-6736(16)30137-4. View

Mathiasen A, Qayyum A, Jorgensen E, Helqvist S, Kofoed K, Haack-Sorensen M . Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4-year follow-up of the MSC-HF trial. Eur J Heart Fail. 2019; 22(5):884-892. DOI: 10.1002/ejhf.1700. View

Mathur A, Fernandez-Aviles F, Bartunek J, Belmans A, Crea F, Dowlut S . The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial. Eur Heart J. 2020; 41(38):3702-3710. PMC: 7666866. DOI: 10.1093/eurheartj/ehaa651. View

Wysoczynski M, Guo Y, Moore 4th J, Muthusamy S, Li Q, Nasr M . Myocardial Reparative Properties of Cardiac Mesenchymal Cells Isolated on the Basis of Adherence. J Am Coll Cardiol. 2017; 69(14):1824-1838. PMC: 5628504. DOI: 10.1016/j.jacc.2017.01.048. View

Bolli R, Tang X, Guo Y, Li Q . After the storm: an objective appraisal of the efficacy of c-kit+ cardiac progenitor cells in preclinical models of heart disease. Can J Physiol Pharmacol. 2020; 99(2):129-139. PMC: 8299902. DOI: 10.1139/cjpp-2020-0406. View

Virani S, Alonso A, Benjamin E, Bittencourt M, Callaway C, Carson A . Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020; 141(9):e139-e596. DOI: 10.1161/CIR.0000000000000757. View

10.

Heldman A, DiFede D, Fishman J, Zambrano J, Trachtenberg B, Karantalis V . Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA. 2013; 311(1):62-73. PMC: 4111133. DOI: 10.1001/jama.2013.282909. View

11.

Vagnozzi R, Maillet M, Sargent M, Khalil H, Johansen A, Schwanekamp J . An acute immune response underlies the benefit of cardiac stem cell therapy. Nature. 2019; 577(7790):405-409. PMC: 6962570. DOI: 10.1038/s41586-019-1802-2. View

12.

Wysoczynski M, Khan A, Bolli R . New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types. Circ Res. 2018; 123(2):138-158. PMC: 6050028. DOI: 10.1161/CIRCRESAHA.118.313251. View

13.

Karantalis V, Hare J . Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res. 2015; 116(8):1413-30. PMC: 4429294. DOI: 10.1161/CIRCRESAHA.116.303614. View

14.

Cai C, Guo Y, Teng L, Nong Y, Tan M, Book M . Preconditioning Human Cardiac Stem Cells with an HO-1 Inducer Exerts Beneficial Effects After Cell Transplantation in the Infarcted Murine Heart. Stem Cells. 2015; 33(12):3596-607. PMC: 4766973. DOI: 10.1002/stem.2198. View

15.

Zhu K, Wu Q, Ni C, Zhang P, Zhong Z, Wu Y . Lack of Remuscularization Following Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells in Infarcted Nonhuman Primates. Circ Res. 2018; 122(7):958-969. DOI: 10.1161/CIRCRESAHA.117.311578. View

16.

Tang X, Nakamura S, Li Q, Wysoczynski M, Gumpert A, Wu W . Repeated Administrations of Cardiac Progenitor Cells Are Superior to a Single Administration of an Equivalent Cumulative Dose. J Am Heart Assoc. 2018; 7(4). PMC: 5850187. DOI: 10.1161/JAHA.117.007400. View

17.

Tang X, Li Q, Rokosh G, Sanganalmath S, Chen N, Ou Q . Long-Term Outcome of Administration of c-kit(POS) Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist.... Circ Res. 2016; 118(7):1091-105. PMC: 4818175. DOI: 10.1161/CIRCRESAHA.115.307647. View

18.

Bolli R, Mitrani R, Hare J, Pepine C, Perin E, Willerson J . A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial. Eur J Heart Fail. 2021; 23(4):661-674. PMC: 8357352. DOI: 10.1002/ejhf.2178. View

19.

Bolli R, Ghafghazi S . Stem cells: Cell therapy for cardiac repair: what is needed to move forward?. Nat Rev Cardiol. 2017; 14(5):257-258. DOI: 10.1038/nrcardio.2017.38. View

20.

Bolli R, Tang X, Sanganalmath S, Rimoldi O, Mosna F, Abdel-Latif A . Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation. 2013; 128(2):122-31. PMC: 3807652. DOI: 10.1161/CIRCULATIONAHA.112.001075. View